DK0500793T3 - Osmotisk oral doseringsform til fertilitetskontrol - Google Patents

Osmotisk oral doseringsform til fertilitetskontrol

Info

Publication number
DK0500793T3
DK0500793T3 DK91900649.4T DK91900649T DK0500793T3 DK 0500793 T3 DK0500793 T3 DK 0500793T3 DK 91900649 T DK91900649 T DK 91900649T DK 0500793 T3 DK0500793 T3 DK 0500793T3
Authority
DK
Denmark
Prior art keywords
dosage form
oral dosage
fertility control
osmotic oral
female
Prior art date
Application number
DK91900649.4T
Other languages
Danish (da)
English (en)
Inventor
Jeri Dawn Wright
Patrick S-L Wong
Linda E Atkinson
Jerry D Childers
Brian L Barclay
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0500793T3 publication Critical patent/DK0500793T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91900649.4T 1989-11-16 1990-11-12 Osmotisk oral doseringsform til fertilitetskontrol DK0500793T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/437,480 US5098714A (en) 1989-11-16 1989-11-16 Osmotic, oral dosage form for fertility control

Publications (1)

Publication Number Publication Date
DK0500793T3 true DK0500793T3 (da) 1994-01-03

Family

ID=23736633

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900649.4T DK0500793T3 (da) 1989-11-16 1990-11-12 Osmotisk oral doseringsform til fertilitetskontrol

Country Status (18)

Country Link
US (1) US5098714A (no)
EP (1) EP0500793B1 (no)
JP (1) JPH05501707A (no)
KR (1) KR920703024A (no)
AT (1) ATE96660T1 (no)
AU (1) AU640231B2 (no)
CA (1) CA2029647A1 (no)
DE (1) DE69004437T2 (no)
DK (1) DK0500793T3 (no)
ES (1) ES2060350T3 (no)
FI (1) FI922206A0 (no)
IE (1) IE62390B1 (no)
MX (1) MX174197B (no)
NO (1) NO921854L (no)
NZ (1) NZ236031A (no)
PT (1) PT95858B (no)
WO (1) WO1991007173A1 (no)
ZA (1) ZA909047B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
AU5681294A (en) * 1992-11-30 1994-06-22 Kv Pharmaceutical Company Tastemasked pharmaceutical materials
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
ATE236639T1 (de) * 1994-09-22 2003-04-15 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
KR20110020782A (ko) * 2008-04-24 2011-03-03 이브스트라, 인코포레이티드 장용 폴리머 중에 분산된 프로게스토겐 및 에스트로겐을 포함하는 경구 피임약 제형
WO2010033832A2 (en) * 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
US20150320675A1 (en) * 2013-01-18 2015-11-12 University Of Utah Research Foundation Modified Release Osmotic Pump for PH-Responsive Drug Delivery
EP3031747B1 (en) * 2014-12-11 2018-10-10 Henkel IP & Holding GmbH Dispensing pack comprising compressible foam/fibre inserts and method for varying the dispensing volume ratio of a dispensing pack

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
NL271831A (no) * 1960-11-29
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
GB2010676B (en) * 1977-12-27 1982-05-19 Alza Corp Diffusional drug delivery device with block copolymer as drug carrier
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4372951A (en) * 1979-10-11 1983-02-08 Nichols Vorys Vaginal delivery for physiologic follicular-luteal steroid treatment
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen

Also Published As

Publication number Publication date
EP0500793A1 (en) 1992-09-02
FI922206A (fi) 1992-05-14
NO921854D0 (no) 1992-05-12
JPH05501707A (ja) 1993-04-02
ZA909047B (en) 1991-09-25
DE69004437D1 (de) 1993-12-09
NZ236031A (en) 1993-05-26
DE69004437T2 (de) 1994-03-03
US5098714A (en) 1992-03-24
WO1991007173A1 (en) 1991-05-30
NO921854L (no) 1992-05-18
IE62390B1 (en) 1995-01-25
ES2060350T3 (es) 1994-11-16
AU7786591A (en) 1991-06-13
IE904062A1 (en) 1991-05-22
KR920703024A (ko) 1992-12-17
FI922206A0 (fi) 1992-05-14
ATE96660T1 (de) 1993-11-15
AU640231B2 (en) 1993-08-19
EP0500793B1 (en) 1993-11-03
CA2029647A1 (en) 1991-05-17
MX174197B (es) 1994-04-27
PT95858A (pt) 1991-09-13
PT95858B (pt) 1998-07-31

Similar Documents

Publication Publication Date Title
DK0500793T3 (da) Osmotisk oral doseringsform til fertilitetskontrol
NO976067L (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
IL92069A0 (en) Contraception system and method
BR8807426A (pt) Composicoes e metodos contraceptivos e controle do cancer de mama
ATE216241T1 (de) Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
HK1019305A1 (en) Progestogen-anti-progestogen regimens
DE3888269D1 (de) Hormon-Zusammensetzung und -Anwendung.
IS4753A (is) Getnaðarvarnaraðferð og -samstæða fyrir kvenkyns spendýr, sem inniheldur samsetningu með gestageni og estrógeni
FI98984B (fi) Ehkäisyvalmiste, joka sisältää ainoastaan progestogeenia
ATE91410T1 (de) Osmotische dosierungsform.
Crist Post-coital estrogen